New High Performance Microplate Reader for Clinical and Research Use
|
By LabMedica International staff writers Posted on 24 Jun 2013 |
|
Image: The CLARIOstar microplate reader (Photo courtesy of BMG Labtech).
Image: The Clariostar's set of monochromators and filters guarantee enhance performance (Photo courtesy of BMG Labtech).
The new CLARIOstar microplate reader from BMG Labtech (Ortenberg, Germany) is the latest evolution in microplate reader instrumentation. This instrument is a multimode microplate reader with advanced LVF (linear variable filter) monochromators, highly sensitive filters, and an ultrafast spectrometer. It is a modular microplate reader, having up to eight different detection modes, including: fluorescence intensity, FRET, fluorescence polarization, luminescence, BRET, UV/Vis absorbance, time-resolved fluorescence, TR-FRET, and AlphaScreen/AphaLISA.
The proprietary AlphaScreen/AlphaLISA assays are performed with a high-energy laser. Kinetic and cell-based assays can be initiated with reagent injectors, and an integrated fluorophore library aids assay development and set up.
Advanced LVF monochromators having continually adjustable wavelengths (320 to 850 nm) and bandwidths (8 to 100 nm) for excitation and for emission significantly increase performance over conventional monochromators. Also, highly sensitive filters can be used in tandem with the advanced LVF monochromators for maximum versatility and sensitivity.
In addition to the advanced LVF monochromators for fluorescence and luminescence assays, the CLARIOstar integrates technologies that enhance other life science assays. Rapid, full spectrum UV/Vis absorbance (220 to 1,000 nm) is performed with BMG Labtech’s proprietary ultrafast spectrometer (less than one second per well). Cell-based assays are greatly improved with 0.1 mm Z-height resolution and cell layer scanning.
CLARIOstar's advanced monochromator system consists of two LVF monochromators and filter selectors, one for excitation and one for emission. In addition, a linear variable dichroic mirror (LVDM) slide is used to separate the excitation from the emission light. The LVF monochromator consists of a linear variable long pass (LVLP) slide and a linear variable short pass (LVSP) slide. The LVLP forms the rising edge while the LVSP forms the falling edge of a bandpass filter. By moving the LVLP and the LVSP slides relative to each other, the system creates a filter with a distinct variable peak wavelength and bandwidth. The manufacturer maintains that enhanced light transmission and better blocking of stray light significantly increase the performance of Clariostar when compared to conventional monochromators.
Related Links:
BMG Labtech
The proprietary AlphaScreen/AlphaLISA assays are performed with a high-energy laser. Kinetic and cell-based assays can be initiated with reagent injectors, and an integrated fluorophore library aids assay development and set up.
Advanced LVF monochromators having continually adjustable wavelengths (320 to 850 nm) and bandwidths (8 to 100 nm) for excitation and for emission significantly increase performance over conventional monochromators. Also, highly sensitive filters can be used in tandem with the advanced LVF monochromators for maximum versatility and sensitivity.
In addition to the advanced LVF monochromators for fluorescence and luminescence assays, the CLARIOstar integrates technologies that enhance other life science assays. Rapid, full spectrum UV/Vis absorbance (220 to 1,000 nm) is performed with BMG Labtech’s proprietary ultrafast spectrometer (less than one second per well). Cell-based assays are greatly improved with 0.1 mm Z-height resolution and cell layer scanning.
CLARIOstar's advanced monochromator system consists of two LVF monochromators and filter selectors, one for excitation and one for emission. In addition, a linear variable dichroic mirror (LVDM) slide is used to separate the excitation from the emission light. The LVF monochromator consists of a linear variable long pass (LVLP) slide and a linear variable short pass (LVSP) slide. The LVLP forms the rising edge while the LVSP forms the falling edge of a bandpass filter. By moving the LVLP and the LVSP slides relative to each other, the system creates a filter with a distinct variable peak wavelength and bandwidth. The manufacturer maintains that enhanced light transmission and better blocking of stray light significantly increase the performance of Clariostar when compared to conventional monochromators.
Related Links:
BMG Labtech
Gold Member
Troponin T QC
Troponin T Quality Control
New
Auto Clinical Chemistry Analyzer
cobas c 703
New
Vaginitis Test
Allplex Vaginitis Screening Assay
Latest Technology News
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
- Paper-Based Biosensor System to Detect Glucose Using Sweat Could Revolutionize Diabetes Management
- First AI-Powered Blood Test Identifies Patients in Earliest Stage of Breast Cancer
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read more
Molecular Diagnostics
view channel
Blood Test Could Predict Relapse of Autoimmune Blood Vessel Disease
Neutrophils, once believed to be uniform in nature, have been discovered to exhibit significant diversity. These immune cells, which play a crucial role in fighting infections, are also implicated in autoimmune... Read more
First-of-its-Kind Blood Test Detects Trauma-Related Diseases
In today’s fast-paced world, stress and trauma have unfortunately become common experiences for many individuals. Continuous exposure to stress hormones can confuse the immune system, causing it to misinterpret... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Pathology
view channel
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more
World’s First AI Model for Thyroid Cancer Diagnosis Achieves Over 90% Accuracy
Thyroid cancer is one of the most common cancers worldwide, and its precise management typically relies on two primary systems: (1) the 8th edition of the American Joint Committee on Cancer (AJCC) or ... Read more
Breakthrough Diagnostic Approach to Significantly Improve TB Detection
Tuberculosis (TB) remains the deadliest infectious disease globally, with 10.8 million new cases and 1.25 million deaths reported in 2023. Early detection through effective screening is crucial in identifying... Read more
Rapid, Ultra-Sensitive, PCR-Free Detection Method Makes Genetic Analysis More Accessible
Genetic testing has been an important method for detecting infectious diseases, diagnosing early-stage cancer, ensuring food safety, and analyzing environmental DNA. For a long time, polymerase chain reaction... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
